Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study

Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study

Abstract Background and aim Peroxisome proliferator-activated receptor-γ (PPAR-γ) modulating treatment may have cardiovascular benefits in type 2 diabetes mellitus (T2DM) patients after ischemic stroke (IS). However, whether there are additional benefits from intensive PPAR-γ modulating treatments i...

Full description

Bibliographic Details
Main Authors: Chi-Hung Liu, Tsong-Hai Lee, Yu-Sheng Lin, Pi-Shan Sung, Yi-Chia Wei, Yan-Rong Li
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Cardiovascular Diabetology
Subjects:
Diabetes mellitus
Hypertension
Ischemic stroke
Pioglitazone
PPAR-γ
Telmisartan
Online Access:https://doi.org/10.1186/s12933-019-0979-x

Internet

https://doi.org/10.1186/s12933-019-0979-x

Similar Items